🚀 VC round data is live in beta, check it out!
- Public Comps
- Hapvida
Hapvida Valuation Multiples
Discover revenue and EBITDA valuation multiples for Hapvida and similar public comparables like ProAssurance, Anadolu Sigorta, Banvida, Progyny and more.
Hapvida Overview
About Hapvida
Hapvida Participacoes Investimento SA is the medical-hospital and dental care company. The company and its subsidiaries are mainly engaged in the sale of health insurance plans and delivering the majority of medical assistance at its own hospitals, clinics, imaging diagnostics and laboratories; and the sale of dental insurance plans for services provided by an accredited network.
Founded
1979
HQ

Employees
74.4K
Website
Financials (LTM)
EV
$3B
Hapvida Financials
Hapvida reported last 12-month revenue of $6B and EBITDA of $585M.
In the same LTM period, Hapvida generated $1B in gross profit, $585M in EBITDA, and had net loss of ($47M).
Revenue (LTM)
Hapvida P&L
In the most recent fiscal year, Hapvida reported revenue of $6B and EBITDA of $809M.
Hapvida expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $6B | XXX | $6B | XXX | XXX | XXX |
| Gross Profit | $1B | XXX | $744M | XXX | XXX | XXX |
| Gross Margin | 22% | XXX | 12% | XXX | XXX | XXX |
| EBITDA | $585M | XXX | $809M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 13% | XXX | XXX | XXX |
| EBIT Margin | 3% | XXX | 6% | XXX | XXX | XXX |
| Net Profit | ($47M) | XXX | ($28M) | XXX | XXX | XXX |
| Net Margin | (1%) | XXX | (0%) | XXX | XXX | XXX |
| Net Debt | — | — | $2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Hapvida Stock Performance
Hapvida has current market cap of $1B, and enterprise value of $3B.
Market Cap Evolution
Hapvida's stock price is $2.65.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $1B | -0.0% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHapvida Valuation Multiples
Hapvida trades at 0.5x EV/Revenue multiple, and 4.7x EV/EBITDA.
EV / Revenue (LTM)
Hapvida Financial Valuation Multiples
As of April 14, 2026, Hapvida has market cap of $1B and EV of $3B.
Equity research analysts estimate Hapvida's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hapvida has a P/E ratio of (26.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 4.7x | XXX | 3.4x | XXX | XXX | XXX |
| EV/EBIT | 13.7x | XXX | 7.3x | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | 3.7x | XXX | XXX | XXX |
| P/E | (26.6x) | XXX | (44.4x) | XXX | XXX | XXX |
| EV/FCF | 8.4x | XXX | 6.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Hapvida Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Hapvida Margins & Growth Rates
Hapvida's revenue in the last 12 month grew by 8%.
Hapvida's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Hapvida's rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hapvida's rule of X is 13% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Hapvida Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 8% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 13% | XXX | XXX | XXX |
| EBITDA Growth | (3%) | XXX | (33%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 13% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | (0%) | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 6% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Hapvida Public Comps
See public comps and valuation multiples for other Health Benefits & Financial Solutions and Insurance Carriers comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Hapvida | XXX | XXX | XXX | XXX | XXX | XXX |
| ProAssurance | XXX | XXX | XXX | XXX | XXX | XXX |
| Anadolu Sigorta | XXX | XXX | XXX | XXX | XXX | XXX |
| Banvida | XXX | XXX | XXX | XXX | XXX | XXX |
| Progyny | XXX | XXX | XXX | XXX | XXX | XXX |
| International General Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hapvida M&A Activity
Hapvida acquired XXX companies to date.
Last acquisition by Hapvida was on XXXXXXXX, XXXXX. Hapvida acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Hapvida
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialHapvida Investment Activity
Hapvida invested in XXX companies to date.
Hapvida made its latest investment on XXXXXXXX, XXXXX. Hapvida invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Hapvida
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Hapvida
| When was Hapvida founded? | Hapvida was founded in 1979. |
| Where is Hapvida headquartered? | Hapvida is headquartered in Brazil. |
| How many employees does Hapvida have? | As of today, Hapvida has over 74K employees. |
| Who is the CEO of Hapvida? | Hapvida's CEO is Jorge Fontoura Pinheiro Koren de Lima. |
| Is Hapvida publicly listed? | Yes, Hapvida is a public company listed on B3. |
| What is the stock symbol of Hapvida? | Hapvida trades under HAPV3 ticker. |
| When did Hapvida go public? | Hapvida went public in 2018. |
| Who are competitors of Hapvida? | Hapvida main competitors are ProAssurance, Anadolu Sigorta, Banvida, Progyny. |
| What is the current market cap of Hapvida? | Hapvida's current market cap is $1B. |
| What is the current revenue of Hapvida? | Hapvida's last 12 months revenue is $6B. |
| What is the current revenue growth of Hapvida? | Hapvida revenue growth (NTM/LTM) is 8%. |
| What is the current EV/Revenue multiple of Hapvida? | Current revenue multiple of Hapvida is 0.5x. |
| Is Hapvida profitable? | Yes, Hapvida is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hapvida? | Hapvida's last 12 months EBITDA is $585M. |
| What is Hapvida's EBITDA margin? | Hapvida's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Hapvida? | Current EBITDA multiple of Hapvida is 4.7x. |
| What is the current FCF of Hapvida? | Hapvida's last 12 months FCF is $329M. |
| What is Hapvida's FCF margin? | Hapvida's last 12 months FCF margin is 5%. |
| What is the current EV/FCF multiple of Hapvida? | Current FCF multiple of Hapvida is 8.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.